6Gleeson HK, Wiley V, Wilcken B, et al . Two - year pilot study of newborn screening for congenital adrenal hyperplasia in New Sorth Wales compared with nationwide case surveillance in Australia[ J]. J Paediatr Child Health,2008,44 ( 10 ) : 554 -559.
7Grunieiro - Papendiecd L, Chiesa A, Mendez V, et al. Neonatal screening for congenital adrenal hyperplasia:esperience and results in Argeintina [ J ]. Pediatrics,2000,106 (6) : 1511 - 1518.
4Soardi FC, Lemos-Marini SH, Coeli FB, et al. Heterozygosis for CYP21A2 mutation considered as 21- hydroxylase deficiency in neonatal screening[ J ]. Arq Bras Endocrinol Metabol,2008,52 ( 8 ) : 1388-1392.
5Van der Kamp HJ, Wit JM. Neonatal screening for congenital adrenal hyperplasia [J]. Eur J Endocrinol, 2004,151 ( Suppl 3 ) : U71-U75.
6Votava F, Torok D, Kovacs J, et al. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia [ J ]. Eur J Endoerinol, 2005,152(6) : 869 -874.
7Gleeson HK, Wiley V, Wilcken B, et al. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia [J].J Paediatr Child Health,2008, 44 (10) :554-559.
8Grunieiro-Papendieck L, Chiesa A, Mendez V, et al. Neonatal screening for congenital adrenal hyperplasia : experience and results in Argentina [ J ]. J Pediatr Endocrinol Metab ,2008,21 ( 1 ) :73-78.
9Technical report: congenital adrenal hyperplasia. Section on endocrinology and committee on genetics [ J]. Pediatrics, 2000,106 ( 6 ) : 1511 - 1518.
10Van der Kamp HJ, Oudshoorn CG,Elvers BH, et al. Cutoff levels of 17-alpha-hydroxyprogsterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight[J].J Clin Endocrinol Metab, 2005,90 (7) :3904-3907.
5Carlson PE, Flanagan CL, Ickes CE, et al. Enzymatic deficiency in primaquine-sen-sitive erythrocytes[J].Science, 1956, 124 (3220):484-485.
6Tang TK, Huang WY, Tang C J, et al. Mol ecular basis of glucose-6-Phosphate de- hydrogenase (G6PD) deficiency in three Taiwan aboriginal tribes[J].Hum Genet, 1995,95(6):630-632.
7Chiang SH, Wu S J, Wu KF, et al. Neo- natal screening for glueose-6-phosphate dehydrogenase deficiency in Taiwan [J]. Southeast Asian J Trop Med Public Hea- lth,1999,30 (Suppll 2):72-74.
8Saha S, SahaN, Tay JS, et al. Molecular characterization of red cell glucose-6- Phosphate dehydrogenase deficiency in Singapore Chinese[J]. Am J Hematol, 1994,47(4):273-277.
9Hsia YE, Miyakawa F, Baltazar J, et al. Frequency of glucose-6-Phosphate de- hydrogenase (G6PD) mutations in Chin- ese, FiliPinos, and Laotians from Hawaii[J]. Hum Genet, 1993, 92(5):470-476.
10Du CS, Xu YK, Hua XY, et al. glucose-6- Phosphate dehydrogenase variants and their frequency in Guangdong, China[J]. Hum Genet,1988,80(4):385-388.
